Deep Track Capital’s Genmab GMAB Stock Holding History

Deep Track Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$98.3M	Buy	+3,663,250	New	+$110M	1.61%	20
2025 Q4	–	Sell	-481,267	Closed	-$14.8M	–	65
2025 Q3	$14.8M	Buy	+481,267	New	+$11.7M	0.41%	40
2025 Q1	–	Sell	-2,000,000	Closed	-$41.7M	–	72
2024 Q4	$41.7M	Buy	+2,000,000	New	+$43.9M	1.56%	20

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Deep Track Capital's GMAB Position: Q1 2026 in Review

Deep Track Capital opened a new position in Genmab (GMAB) in Q1 2026: 3,663,250 shares worth $98.3M. The stake represents 1.61% of the portfolio and ranks #20 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in GMAB as recently as Q3 2025.

Deep Track Capital first reported a position in GMAB in Q4 2024 and has held it in 3 quarters since. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

Deep Track Capital held 3,663,250 shares of Genmab worth $98.3M as of Q1 2026.
Genmab was a new Deep Track Capital position in Q1 2026.
Genmab made up 1.61% of Deep Track Capital's portfolio in Q1 2026, its #20 holding.
Deep Track Capital first reported a position in Genmab in Q4 2024 and has held it in 3 quarters since.
272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.